TNX-4800 for the Prevention of Lyme disease in the U.S.: Global Lyme Alliance Presentation

Tonix Pharmaceuticals Holding Corp. published this content on May 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 18, 2026 at 13:51 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]